Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRMT5 | O14744 | 15/20 | 0.37 |
| ▸ | WDR77 | Q9BQA1 | 15/20 | 0.37 |
| ▸ | PI4KA | P42356 | 1/20 | 0.32 |
| ▸ | PI4K2B | Q8TCG2 | 1/20 | 0.32 |
| ▸ | PI4K2A | Q9BTU6 | 1/20 | 0.32 |
| ▸ | PI4KB | Q9UBF8 | 1/20 | 0.32 |
| ▸ | HRH2 | P25021 | 1/20 | 0.31 |
| ▸ | HTR5A | P47898 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22521487 | 0.84 | HTR2B (0.38) | PRMT5WDR77HRH2HTR5A | |
| SCHEMBL23430009 | 0.84 | HTR2B (0.38) | PRMT5WDR77HRH2HTR5A | |
| SCHEMBL29566386 | 0.84 | HTR2B (0.38) | PRMT5WDR77HRH2HTR5A | |
| SCHEMBL22521414 | 0.84 | HTR2B (0.38) | PRMT5WDR77HRH2HTR5A | |
| SCHEMBL22509807 | 0.82 | PRMT5 (0.35) | PRMT5WDR77PI4KAPI4K2BPI4K2A | |
| SCHEMBL22787756 | 0.82 | PRMT5 (0.35) | PRMT5WDR77PI4KAPI4K2BPI4K2A | |
| SCHEMBL21682243 | 0.81 | PRMT5 (0.40) | PRMT5WDR77PI4KAPI4K2BPI4K2A | |
| SCHEMBL22509701 | 0.81 | PRMT5 (0.36) | PRMT5WDR77PI4KAPI4K2BPI4K2A | |
| SCHEMBL24659488 | 0.78 | PRMT5 (0.36) | PRMT5WDR77 | |
| SCHEMBL23786794 | 0.78 | PRMT5 (0.37) | PRMT5WDR77PI4KAPI4K2BPI4K2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019116302-A1 | SUBSTITUTED BICYCLIC HETEROCYCLIC COMPOUNDS AS PRMT5 INHIBITORS | LUPIN LIMITED (IN) | 2019-06-20 | — | — | WO | disclosed |